ECO Animal Health Group (LON:EAH) Reaches New 1-Year High - Still a Buy?

Key Points

• ECO Animal Health Group shares reached a new 52-week high of GBX 100 ($1.34) during mid-day trading, reflecting strong demand with a trading volume of 280,931 shares.
• Shore Capital reaffirmed a "buy" rating for the stock and set a price target of GBX 150, with the average rating from analysts also being "Buy."
• Insider David Hallas purchased 29,897 shares at an average price of GBX 67 per share, indicating confidence in the company's future performance.

ECO Animal Health Group plc (LON:EAH - Get Free Report) shares reached a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 100 ($1.34) and last traded at GBX 96.31 ($1.29), with a volume of 280931 shares trading hands. The stock had previously closed at GBX 99.10 ($1.33).

Wall Street Analyst Weigh In

Separately, Shore Capital reaffirmed a "buy" rating and issued a GBX 150 price target on shares of ECO Animal Health Group in a report on Monday, July 14th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, ECO Animal Health Group currently has an average rating of "Buy" and an average target price of GBX 150.

ECO Animal Health Group Stock Down 2.8%

The company has a market capitalization of £65.00 million, a price-to-earnings ratio of 3,963.37 and a beta of -0.05. The stock's fifty day simple moving average is GBX 77.15 and its two-hundred day simple moving average is GBX 66.14. The company has a debt-to-equity ratio of 4.81, a current ratio of 2.96 and a quick ratio of 2.14.

ECO Animal Health Group (LON:EAH - Get Free Report) last issued its earnings results on Monday, July 14th. The company reported GBX 2.49 earnings per share for the quarter. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.

Insider Buying and Selling at ECO Animal Health Group

In other news, insider David Hallas acquired 29,897 shares of the company's stock in a transaction that occurred on Tuesday, July 15th. The shares were acquired at an average price of GBX 67 per share, with a total value of £20,030.99. 11.03% of the stock is currently owned by company insiders.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.